Article

Machine Learning Identifies Novel Candidates for Drug Repurposing in Alzheimer’s Disease

2020-05-16

Abstract excerpt

Clinical trials of novel therapeutics for Alzheimer’s Disease (AD) have consumed a large amount of time and resources with largely negative results. Repurposing drugs already approved by the Food and Drug Administration (FDA) for another indication is a more rapid and less expensive option. Repurposing can yield a useful therapeutic and also accelerate proof of concept studies that ultimately lead to a new molecul...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c821cc97-4051-5d3b-a895-f617d0f88c11
DOI: 10.1101/2020.05.15.098749

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Machine Learning Identifies Novel Candidates for Drug Repurposing in Alzheimer’s DiseaseDOI 10.1101/2020.05.15.098749Read

AI-based mining of biomedical literature: Applications for drug repurposing for the treatment of dementiaSemantic proximity Read

AI-based mining of biomedical literature: Applications for drug repurposing for the treatment of dementiaSemantic proximity Read

Network pharmacology-based discovery and experimental validation of novel drug repurposing candidates in Alzheimer’s DiseaseSemantic proximity Read

A 5-repurposed drug candidates identified in motor neurons and muscle tissues with amyotrophic lateral sclerosis by network biology and machine learning based on gene expressionSemantic proximity Read

Identifying Novel Candidates for Re-Purposing as Potential Therapeutic Agents for Alzheimer’s diseaseSemantic proximity Read

Artificial intelligence for drug discovery and development in Alzheimer's diseaseSemantic proximity Read

Unveiling disulfidptosis-related biomarkers and predicting drugs in Alzheimer’s diseaseSemantic proximity Read

5-Repurposed Drug Candidates Identified in Motor Neurons and Muscle Tissues with Amyotrophic Lateral Sclerosis by Network Biology and Machine Learning Based on Gene ExpressionSemantic proximity Read

A New Approach to Drug Repurposing with Two-Stage Prediction, Machine Learning, and Unsupervised Clustering of Gene ExpressionSemantic proximity Read

Integrative Omics for Informed Drug Repurposing: Targeting CNS DisordersSemantic proximity Read

Exploratory Analysis of iPSCS-Derived Neuronal Cells as Predictors of Diagnosis and Treatment of Alzheimer DiseaseSemantic proximity Read

Screening novel drug candidates for Alzheimer’s disease by an integrated network and transcriptome analysisSemantic proximity Read